(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione

C102H90FN21O15S — CID 160733336

IUPAC(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione
SMILESCOc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4c(C)nn(C)c4C)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4ccc(-c5ccccn5)s4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4ncnc5c4ncn5C)cc3)NC(=O)NC1=O)C2.Cc1nn(C)c(C)c1-c1ccc([C@]2(CN3Cc4ccc(F)cc4C3=O)NC(=O)NC2=O)cc1
InChIInChI=1S/C28H22N4O4S.C25H21N7O4.C25H25N5O4.C24H22FN5O3/c1-36-20-10-7-18-15-32(25(33)21(18)14-20)16-28(26(34)30-27(35)31-28)19-8-5-17(6-9-19)23-11-12-24(37-23)22-4-2-3-13-29-22;1-31-13-28-20-19(26-12-27-21(20)31)14-3-6-16(7-4-14)25(23(34)29-24(35)30-25)11-32-10-15-5-8-17(36-2)9-18(15)22(32)33;1-14-21(15(2)29(3)28-14)16-5-8-18(9-6-16)25(23(32)26-24(33)27-25)13-30-12-17-7-10-19(34-4)11-20(17)22(30)31;1-13-20(14(2)29(3)28-13)15-4-7-17(8-5-15)24(22(32)26-23(33)27-24)12-30-11-16-6-9-18(25)10-19(16)21(30)31/h2-14H,15-16H2,1H3,(H2,30,31,34,35);3-9,12-13H,10-11H2,1-2H3,(H2,29,30,34,35);5-11H,12-13H2,1-4H3,(H2,26,27,32,33);4-10H,11-12H2,1-3H3,(H2,26,27,32,33)/t28-;2*25-;24-/m0000/s1
InChIKeyRUQASUKEYWPHNY-FBQHIDHMSA-N
MW1901.04 g/mol
LogP10.84
Rot. Bonds20

About (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione

(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione (PubChem CID 160733336) has the molecular formula C102H90FN21O15S and a molecular weight of 1901.04 g/mol. Its IUPAC name is (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione.

Molecular Properties

Compound Name(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione
PubChem CID160733336
Molecular FormulaC102H90FN21O15S
Molecular Weight1901.04 g/mol
Exact Mass1899.66
IUPAC Name(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione
SMILESCOc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4c(C)nn(C)c4C)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4ccc(-c5ccccn5)s4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4ncnc5c4ncn5C)cc3)NC(=O)NC1=O)C2.Cc1nn(C)c(C)c1-c1ccc([C@]2(CN3Cc4ccc(F)cc4C3=O)NC(=O)NC2=O)cc1
InChIInChI=1S/C28H22N4O4S.C25H21N7O4.C25H25N5O4.C24H22FN5O3/c1-36-20-10-7-18-15-32(25(33)21(18)14-20)16-28(26(34)30-27(35)31-28)19-8-5-17(6-9-19)23-11-12-24(37-23)22-4-2-3-13-29-22;1-31-13-28-20-19(26-12-27-21(20)31)14-3-6-16(7-4-14)25(23(34)29-24(35)30-25)11-32-10-15-5-8-17(36-2)9-18(15)22(32)33;1-14-21(15(2)29(3)28-14)16-5-8-18(9-6-16)25(23(32)26-24(33)27-25)13-30-12-17-7-10-19(34-4)11-20(17)22(30)31;1-13-20(14(2)29(3)28-13)15-4-7-17(8-5-15)24(22(32)26-23(33)27-24)12-30-11-16-6-9-18(25)10-19(16)21(30)31/h2-14H,15-16H2,1H3,(H2,30,31,34,35);3-9,12-13H,10-11H2,1-2H3,(H2,29,30,34,35);5-11H,12-13H2,1-4H3,(H2,26,27,32,33);4-10H,11-12H2,1-3H3,(H2,26,27,32,33)/t28-;2*25-;24-/m0000/s1
InChIKeyRUQASUKEYWPHNY-FBQHIDHMSA-N
XLogP10.84
TPSA433.86 Ų
H-Bond Donors8
H-Bond Acceptors25
Rotatable Bonds20
Heavy Atoms140
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001901.04
LogP ≤ 510.84
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione?
The IUPAC name of (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione (CID 160733336) is (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione.
What is the SMILES notation for (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione?
The canonical SMILES for (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione is COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4c(C)nn(C)c4C)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4ccc(-c5ccccn5)s4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4ncnc5c4ncn5C)cc3)NC(=O)NC1=O)C2.Cc1nn(C)c(C)c1-c1ccc([C@]2(CN3Cc4ccc(F)cc4C3=O)NC(=O)NC2=O)cc1.
What is the InChIKey of (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione?
The InChIKey is RUQASUKEYWPHNY-FBQHIDHMSA-N. The full InChI is InChI=1S/C28H22N4O4S.C25H21N7O4.C25H25N5O4.C24H22FN5O3/c1-36-20-10-7-18-15-32(25(33)21(18)14-20)16-28(26(34)30-27(35)31-28)19-8-5-17(6-9-19)23-11-12-24(37-23)22-4-2-3-13-29-22;1-31-13-28-20-19(26-12-27-21(20)31)14-3-6-16(7-4-14)25(23(34)29-24(35)30-25)11-32-10-15-5-8-17(36-2)9-18(15)22(32)33;1-14-21(15(2)29(3)28-14)16-5-8-18(9-6-16)25(23(32)26-24(33)27-25)13-30-12-17-7-10-19(34-4)11-20(17)22(30)31;1-13-20(14(2)29(3)28-13)15-4-7-17(8-5-15)24(22(32)26-23(33)27-24)12-30-11-16-6-9-18(25)10-19(16)21(30)31/h2-14H,15-16H2,1H3,(H2,30,31,34,35);3-9,12-13H,10-11H2,1-2H3,(H2,29,30,34,35);5-11H,12-13H2,1-4H3,(H2,26,27,32,33);4-10H,11-12H2,1-3H3,(H2,26,27,32,33)/t28-;2*25-;24-/m0000/s1.
What are the key properties of (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione?
(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione has a molecular weight of 1901.04 g/mol, XLogP of 10.84, 20 rotatable bonds, 8 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(9-methylpurin-6-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(5-pyridin-2-ylthiophen-2-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]imidazolidine-2,4-dione is sourced from PubChem (CID 160733336), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).